teva ceo News and latest stories

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

Israel's Teva Pharmaceuticals and GlaxoSmithKline (GSK) have been disputing over this patent lawsuit since 2014.

By REUTERS

Hot Opinion

Israel's mental health crisis is not looming, it's already here

By JPOST EDITORIAL

Ramadan and Passover: Amid the violence, a sign of hope

By MARC SCHNEIER

The two-state obsession: It’s about constraining Israel - opinion

By DOUGLAS ALTABEF

We’ve never faced a threat like this: We need to act now

By MICHAEL MASTERS

Following Iran's attack, more US aid is needed for Israel

By MARTIN OLINER

The Jerusalem Post Customer Service Center can be contacted with any questions or requests:
Telephone: *2421 * Extension 4 Jerusalem Post or 03-7619056 Fax: 03-5613699 E-mail: subs@jpost.com
The center is staffed and provides answers on Sundays through Thursdays between 07:00 AM and 14:00 PM and Fridays only handles distribution requests between 7:00 AM and 12:30 PM
For international customers: The center is staffed and provides answers on Sundays through Thursdays between 7AM and 14PM Israel time Toll Free number 1-800-448-9291 Telephone +972-3-761-9056 Fax: 972-3-561-3699 E-mail: subs@jpost.com

teva ceo

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

IDF has decided on type, not timing, of counter-strike on Iran

Iran's advanced armament leaves Hamas's rocket system in the dust

14 IDF soldiers, 4 civilians wounded by Hezbollah drones, missiles

Holocaust center director leaves after heckling, lack of support

Countries helped during Iran's attack because Israel is their firewall

Israel's mental health crisis is not looming, it's already here

Ramadan and Passover: Amid the violence, a sign of hope

The two-state obsession: It’s about constraining Israel - opinion

We’ve never faced a threat like this: We need to act now

Following Iran's attack, more US aid is needed for Israel